questionsmedicales.fr
Bactéries
Proteobacteria
Gammaproteobacteria
Vibrionaceae
Vibrio
Vibrio cholerae
Vibrio cholerae : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Choléra
Diagnostic microbiologique
Tests de diagnostic
Vibrio cholerae
Période d'incubation
Choléra
Symptômes
5
Choléra
Portage asymptomatique
Traitements
5
Traitement du choléra
Réhydratation
Efficacité du traitement
Choléra
Facteurs de risque
5
Facteurs de risque
Choléra
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae : Questions médicales les plus fréquentes",
"headline": "Vibrio cholerae : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vibrio cholerae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-28",
"dateModified": "2025-04-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vibrio",
"url": "https://questionsmedicales.fr/mesh/D014733",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio",
"code": {
"@type": "MedicalCode",
"code": "D014733",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae non-O1",
"alternateName": "Vibrio cholerae non-O1",
"url": "https://questionsmedicales.fr/mesh/D044163",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae non-O1",
"code": {
"@type": "MedicalCode",
"code": "D044163",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O1",
"alternateName": "Vibrio cholerae O1",
"url": "https://questionsmedicales.fr/mesh/D041241",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O1",
"code": {
"@type": "MedicalCode",
"code": "D041241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.151"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O139",
"alternateName": "Vibrio cholerae O139",
"url": "https://questionsmedicales.fr/mesh/D041242",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O139",
"code": {
"@type": "MedicalCode",
"code": "D041242",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.200"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae",
"alternateName": "Vibrio cholerae",
"code": {
"@type": "MedicalCode",
"code": "D014734",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Firdausi Qadri",
"url": "https://questionsmedicales.fr/author/Firdausi%20Qadri",
"affiliation": {
"@type": "Organization",
"name": "Infectious Diseases Division, icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh."
}
},
{
"@type": "Person",
"name": "Munirul Alam",
"url": "https://questionsmedicales.fr/author/Munirul%20Alam",
"affiliation": {
"@type": "Organization",
"name": "International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh."
}
},
{
"@type": "Person",
"name": "Shanta Dutta",
"url": "https://questionsmedicales.fr/author/Shanta%20Dutta",
"affiliation": {
"@type": "Organization",
"name": "National Institute of Cholera and Enteric Diseases, NICED-JICA Building, 57 Dr. S.C. Banerjee Road, Beliaghata, Kolkata, 700 010, India."
}
},
{
"@type": "Person",
"name": "Shelley M Payne",
"url": "https://questionsmedicales.fr/author/Shelley%20M%20Payne",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Biosciences and LaMontagne Center for Infectious Diseases, The University of Texas at Austin, Austin, Texas, USA payne@utexas.edu."
}
},
{
"@type": "Person",
"name": "Bibhuti Bhusan Pal",
"url": "https://questionsmedicales.fr/author/Bibhuti%20Bhusan%20Pal",
"affiliation": {
"@type": "Organization",
"name": "Microbiology Division, ICMR-Regional Medical Research Centre, Chandrasekharpur, Bhubaneswar, 751023, Orissa, India. Electronic address: bbpal_rmrc@yahoo.co.in."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Impact of Shiga-toxin encoding gene transduction from O80:H2 Shiga toxigenic Escherichia coli (STEC) on non-STEC strains.",
"datePublished": "2022-12-14",
"url": "https://questionsmedicales.fr/article/36517572",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-26198-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "A unique peptide-based pharmacophore identifies an inhibitory compound against the A-subunit of Shiga toxin.",
"datePublished": "2022-07-06",
"url": "https://questionsmedicales.fr/article/35794188",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-15316-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of an Eco-Friendly Cuminaldehyde Guanylhydrazone Disinfectant on Shiga Toxin Production and Global Transcription of",
"datePublished": "2022-11-02",
"url": "https://questionsmedicales.fr/article/36356001",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/toxins14110752"
}
},
{
"@type": "ScholarlyArticle",
"name": "Volume expansion mitigates Shiga toxin-producing E. coli-hemolytic uremic syndrome in children.",
"datePublished": "2024-01-19",
"url": "https://questionsmedicales.fr/article/38240870",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00467-023-06276-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Heparin-induced thrombocytopenia following Shiga-toxin-associated hemolytic uremic syndrome: a case report.",
"datePublished": "2022-10-23",
"url": "https://questionsmedicales.fr/article/36273193",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13256-022-03627-w"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Bactéries",
"item": "https://questionsmedicales.fr/mesh/D001419"
},
{
"@type": "ListItem",
"position": 3,
"name": "Proteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020560"
},
{
"@type": "ListItem",
"position": 4,
"name": "Gammaproteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020563"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vibrionaceae",
"item": "https://questionsmedicales.fr/mesh/D014737"
},
{
"@type": "ListItem",
"position": 6,
"name": "Vibrio",
"item": "https://questionsmedicales.fr/mesh/D014733"
},
{
"@type": "ListItem",
"position": 7,
"name": "Vibrio cholerae",
"item": "https://questionsmedicales.fr/mesh/D014734"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vibrio cholerae - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vibrio cholerae",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vibrio cholerae",
"description": "Comment diagnostiquer une infection par Vibrio cholerae ?\nQuels tests sont utilisés pour confirmer le choléra ?\nQuels symptômes indiquent une infection par Vibrio cholerae ?\nQuelle est la période d'incubation du choléra ?\nComment différencier le choléra d'autres diarrhées ?",
"url": "https://questionsmedicales.fr/mesh/D014734?mesh_terms=Shiga+Toxin#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vibrio cholerae",
"description": "Quels sont les principaux symptômes du choléra ?\nComment se manifeste la déshydratation dans le choléra ?\nLe choléra peut-il être asymptomatique ?\nQuels signes indiquent une déshydratation sévère ?\nLes symptômes du choléra apparaissent-ils rapidement ?",
"url": "https://questionsmedicales.fr/mesh/D014734?mesh_terms=Shiga+Toxin#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vibrio cholerae",
"description": "Comment prévenir l'infection par Vibrio cholerae ?\nLa vaccination contre le choléra est-elle efficace ?\nQuelles mesures d'hygiène sont recommandées ?\nComment l'eau potable peut-elle prévenir le choléra ?\nLes voyages dans des zones à risque nécessitent-ils des précautions ?",
"url": "https://questionsmedicales.fr/mesh/D014734?mesh_terms=Shiga+Toxin#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vibrio cholerae",
"description": "Quel est le traitement principal du choléra ?\nLes antibiotiques sont-ils nécessaires pour le choléra ?\nComment prévenir la déshydratation dans le choléra ?\nQuels médicaments sont utilisés pour traiter le choléra ?\nLe traitement du choléra est-il efficace ?",
"url": "https://questionsmedicales.fr/mesh/D014734?mesh_terms=Shiga+Toxin#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vibrio cholerae",
"description": "Quelles sont les complications possibles du choléra ?\nLe choléra peut-il entraîner la mort ?\nComment la déshydratation affecte-t-elle le corps ?\nQuelles sont les conséquences à long terme du choléra ?\nLe choléra peut-il causer des épidémies ?",
"url": "https://questionsmedicales.fr/mesh/D014734?mesh_terms=Shiga+Toxin#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vibrio cholerae",
"description": "Quels sont les facteurs de risque du choléra ?\nLes enfants sont-ils plus à risque de choléra ?\nComment la malnutrition influence-t-elle le choléra ?\nLes personnes vivant dans des zones urbaines sont-elles à risque ?\nLes voyageurs peuvent-ils être exposés au choléra ?",
"url": "https://questionsmedicales.fr/mesh/D014734?mesh_terms=Shiga+Toxin#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Vibrio cholerae ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par culture de selles ou tests PCR pour détecter la bactérie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le choléra ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de culture des selles et les tests rapides de détection d'antigènes sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection par Vibrio cholerae ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent diarrhée aqueuse, vomissements et déshydratation rapide."
}
},
{
"@type": "Question",
"name": "Quelle est la période d'incubation du choléra ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La période d'incubation est généralement de 1 à 5 jours après l'exposition."
}
},
{
"@type": "Question",
"name": "Comment différencier le choléra d'autres diarrhées ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choléra se caractérise par une diarrhée aqueuse profuse et une déshydratation rapide."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux symptômes du choléra ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux symptômes sont diarrhée aqueuse, vomissements, crampes abdominales."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la déshydratation dans le choléra ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déshydratation se manifeste par soif intense, sécheresse de la peau et fatigue."
}
},
{
"@type": "Question",
"name": "Le choléra peut-il être asymptomatique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent être porteuses sans présenter de symptômes."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une déshydratation sévère ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent confusion, tachycardie, hypotension et urines très rares."
}
},
{
"@type": "Question",
"name": "Les symptômes du choléra apparaissent-ils rapidement ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent apparaître rapidement, souvent dans les 24 heures."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par Vibrio cholerae ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'accès à l'eau potable, l'hygiène et la vaccination."
}
},
{
"@type": "Question",
"name": "La vaccination contre le choléra est-elle efficace ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins peuvent réduire le risque d'infection, surtout en zones à risque."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains fréquemment et consommer des aliments bien cuits sont essentiels."
}
},
{
"@type": "Question",
"name": "Comment l'eau potable peut-elle prévenir le choléra ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'eau potable et propre empêche l'ingestion de Vibrio cholerae, réduisant le risque."
}
},
{
"@type": "Question",
"name": "Les voyages dans des zones à risque nécessitent-ils des précautions ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est conseillé de se faire vacciner et de suivre des mesures d'hygiène strictes."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal du choléra ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est la réhydratation orale ou intraveineuse selon la gravité."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils nécessaires pour le choléra ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques peuvent être utilisés pour réduire la durée de la diarrhée et la gravité."
}
},
{
"@type": "Question",
"name": "Comment prévenir la déshydratation dans le choléra ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réhydratation rapide avec des solutions de réhydratation orale est essentielle."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour traiter le choléra ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques comme la doxycycline ou l'azithromycine sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "Le traitement du choléra est-il efficace ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un traitement rapide et approprié est très efficace pour réduire la mortalité."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du choléra ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent déshydratation sévère, choc hypovolémique et insuffisance rénale."
}
},
{
"@type": "Question",
"name": "Le choléra peut-il entraîner la mort ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement rapide, le choléra peut être mortel en raison de la déshydratation."
}
},
{
"@type": "Question",
"name": "Comment la déshydratation affecte-t-elle le corps ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déshydratation peut entraîner des déséquilibres électrolytiques et des défaillances organiques."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences à long terme du choléra ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les conséquences peuvent inclure des problèmes de santé persistants, comme des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Le choléra peut-il causer des épidémies ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le choléra peut provoquer des épidémies, surtout dans des conditions d'hygiène précaires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du choléra ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'accès limité à l'eau potable, la malnutrition et l'absence d'hygiène."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque de choléra ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants et les personnes âgées sont plus vulnérables aux complications du choléra."
}
},
{
"@type": "Question",
"name": "Comment la malnutrition influence-t-elle le choléra ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "La malnutrition affaiblit le système immunitaire, augmentant le risque d'infection par choléra."
}
},
{
"@type": "Question",
"name": "Les personnes vivant dans des zones urbaines sont-elles à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les zones urbaines surpeuplées avec un accès limité à l'eau potable sont à risque."
}
},
{
"@type": "Question",
"name": "Les voyageurs peuvent-ils être exposés au choléra ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs dans des régions endommagées par le choléra doivent prendre des précautions."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 22/04/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Infectious Diseases Division, icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
Publications dans "Vibrio cholerae" :
5 publications dans cette catégorie
Affiliations :
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Publications dans "Vibrio cholerae" :
5 publications dans cette catégorie
Affiliations :
National Institute of Cholera and Enteric Diseases, NICED-JICA Building, 57 Dr. S.C. Banerjee Road, Beliaghata, Kolkata, 700 010, India.
Publications dans "Vibrio cholerae" :
4 publications dans cette catégorie
Affiliations :
Department of Molecular Biosciences and LaMontagne Center for Infectious Diseases, The University of Texas at Austin, Austin, Texas, USA payne@utexas.edu.
Publications dans "Vibrio cholerae" :
4 publications dans cette catégorie
Affiliations :
Microbiology Division, ICMR-Regional Medical Research Centre, Chandrasekharpur, Bhubaneswar, 751023, Orissa, India. Electronic address: bbpal_rmrc@yahoo.co.in.
Publications dans "Vibrio cholerae" :
4 publications dans cette catégorie
Affiliations :
Microbiology Division, ICMR-Regional Medical Research Centre, Chandrasekharpur, Bhubaneswar, 751023, Orissa, India. Electronic address: smruti2007rkl@gmail.com.
Publications dans "Vibrio cholerae" :
4 publications dans cette catégorie
Affiliations :
Molecular Genetics Laboratory, Centre for Human Microbial Ecology, Translational Health Science and Technology Institute, NCR Biotech Science Cluster, Faridabad 121001, India; School of Life Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India. Electronic address: bhabatosh@thsti.res.in.
Publications dans "Vibrio cholerae" :
4 publications dans cette catégorie
Affiliations :
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Publications dans "Vibrio cholerae" :
4 publications dans cette catégorie
Affiliations :
National Institute of Cholera and Enteric Diseases, NICED-JICA Building, 57 Dr. S.C. Banerjee Road, Beliaghata, Kolkata, 700 010, India.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Maryland Pathogen Research Institute, University of Maryland, College Park, MD, 20742, USA.
Institute for Advanced Computer Studies, University of Maryland, University of Maryland, College Park, MD, 20742, USA.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Division of Global Health, Massachusetts General Hospital for Children, Boston, Massachusetts, USA.
Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Infectious diseases division, icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Infectious diseases division, icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Microbiology Division, ICMR-Regional Medical Research Centre, India.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA; Department of Microbiology, Harvard Medical School, Boston, MA, USA; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, MA, USA; Howard Hughes Medical Institute, Bethesda, MD, USA. Electronic address: mwaldor@research.bwh.harvard.edu.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
National Institute of Cholera and Enteric Diseases, NICED-JICA Building, 57 Dr. S.C. Banerjee Road, Beliaghata, Kolkata, 700 010, India.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Graduate School of Medicine, Dentistry and Pharmaceutical Sciences of Okayama University, 1-1-1 Tsushima-naka, Kita-ku, Okayama, Okayama, 700-8530, Japan. Electronic address: k-oka@xd6.so-net.ne.jp.
Publications dans "Vibrio cholerae" :
2 publications dans cette catégorie
Affiliations :
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh.
Publications dans "Vibrio cholerae" :
Shiga toxin-producing Escherichia coli (STEC) are major foodborne pathogens that cause human diseases ranging from diarrhea to life-threatening complications including hemolytic-uremic syndrome. Virul...
Shiga toxin (Stx), a major virulence factor of enterohemorrhagic Escherichia coli (EHEC), can cause fatal systemic complications. Recently, we identified a potent inhibitory peptide that binds to the ...
Antimicrobials have been important medicines used to treat various infections. However, some antibiotics increase the expression of Shiga toxin (Stx). Also, the pervasive use of persistent antibiotics...
Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS) is associated with high morbidity and relevant mortality. Previous small studies showed that volume expansion could improve the cours...
Data of pediatric patients with STEC-HUS were analyzed retrospectively. Course and outcome of patients treated with volume expansion (VE) from 2019 to 2022 (n = 38) were compared to historical control...
Patients in the VE group had a significant relative median weight gain compared to HC (7.8% (3.4-11.3) vs. 1.2% (- 0.7-3.9), p < 0.0001) 48 h after admission. The need for dialysis was not reduced by ...
This study suggests that volume expansion may be associated with the mitigation of the acute course of STEC-HUS, especially severe neurological involvement and the development of CKD. Prospective tria...
Up to 50% of cases of Shiga-toxin-producing Escherichia coli hemolytic uremic syndrome occur in adults, and the clinical presentation is variable. Microbiological analyses must be performed in all pat...
A 79-year-old Caucasian woman was admitted to hospital because of severe proctitis. In the following days, the patient's level of consciousness declined, and she developed acute kidney injury, thrombo...
A discordant evolution of platelet count in patients with thrombotic microangiopathy requires a systematic reevaluation of the thrombocytopenia....
Background : Mesenchymal stem cells (MSCs) can be activated by different bacterial toxins. Lipopolysaccharides and Shiga Toxin (Stx) are the main toxins necessary for hemolytic uremic syndrome develop...
Lytic bacteriophages are considered safe for human consumption as biocontrol agents against foodborne pathogens, in particular in ready-to-eat foodstuffs. Phages could, however, evolve to infect diffe...
We aimed to describe the genomic epidemiology of the foodborne gastrointestinal pathogen, Shiga toxin-producing Escherichia coli (STEC) serotype O26:H11 belonging to clonal complex 29 (CC29) in Englan...
Between 01 January 2014 and 31 December 2021, 834 human isolates belonging to CC29 were sequenced at the UK Health Security Agency, and the genomic data was integrated with epidemiological data....
Diagnoses of STEC O26:H11 in England have increased each year from 19 in 2014 to 144 in 2021. Most isolates had the Shiga toxin subtype profiles stx1a (47%), stx1a,stx2a (n = 24%) or stx2a (n = 28%). ...
STEC O26:H11 are a clinically significant, emerging threat to public health in England. Determining the true incidence and prevalence is challenging due to inconsistent national surveillance strategie...
In Argentina, Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli (STEC HUS), is the main cause of acute kidney injury and the second cause of end-stage renal disease (ESRD) in ...
All patients who underwent KTx at our institution were evaluated. The cohort was divided into quintiles (Q), and we compared the cumulative incidence of HUS-related KTx vs KTx due to other etiologies....
A total of 1000 consecutive KTx were included. The cumulative incidence of HUS-related KTx was 11%. HUS was the second cause of KTx in Q1: 17% (1988-1995); Q2: 13.5% (1996-2003); Q3: 11.5% (2004-2009)...
In this cohort, the cumulative incidence of HUS-related KTx decreased, which may have been due to the implementation of nephroprotective strategies....
Diarrheagenic...
We determined the effect of supernatants obtained from CW and EA cultures on the gene expression of STEC strain 86-24 and EAEC strain 042 by RNA-seq analysis. We evaluated IL-8 secretion from T84 cell...
RNA-seq analysis revealed that several virulence factors in STEC and EAEC were upregulated in the presence of supernatants from CW and EA. Interestingly, an increase in the secretion of IL-8 was obser...
Supernatant obtained from an indicative species of DEC-positive diarrhea could modulate gene expression in STEC and EAEC, and IL-8 secretion induced by these bacteria. These data provide new insights ...